Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome

Molecular Findings and Genotype-Phenotype Correlations

Juan Arredondo, Marian Lara, Sídney M. Gospe, Claudio G. Mazia, Maria Vaccarezza, Marcela Garcia-Erro, Constance M. Bowe, Celia H Chang, Michelle M. Mezei, Ricardo A Maselli

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Choline acetyltransferase catalyzes the synthesis of acetylcholine at cholinergic nerves. Mutations in human CHAT cause a congenital myasthenic syndrome due to impaired synthesis of ACh; this severe variant of the disease is frequently associated with unexpected episodes of potentially fatal apnea. The severity of this condition varies remarkably, and the molecular factors determining this variability are poorly understood. Furthermore, genotype-phenotype correlations have been difficult to establish in patients with biallelic mutations. We analyzed the protein expression of phosphorylated ChAT of seven CHAT mutations, p.Val136Met, p.Arg207His, p.Arg186Trp, p.Val194Leu, p.Pro211Ala, p.Arg566Cys, and p.Ser694Cys, in HEK-293 cells to phosphorylated ChAT, determined their enzyme kinetics and thermal stability, and examined their structural changes. Three mutations, p.Arg207His, p.Arg186Trp, and p.Arg566Cys, are novel, and p.Val136Met and p.Arg207His are homozygous in three families and associated with severe disease. The characterization of mutants showed a decrease in the overall catalytic efficiency of ChAT; in particular, those located near the active-site tunnel produced the most seriously disruptive phenotypic effects. On the other hand, p.Val136Met, which is located far from both active and substrate-binding sites, produced the most drastic reduction of ChAT expression. Overall, CHAT mutations producing low enzyme expression and severe kinetic effects are associated with the most severe phenotypes. We investigated the expression and enzyme kinetics of seven phosphorylated choline acetyltransferase (ChAT) mutants causing congenital myasthenic syndrome. The enzyme kinetics of ChAT mutants expressed in HEK cells was investigated using the Fonnum method and the structure was analyzed using the Swiss-PdbViewer program. We found that ChAT mutants resulting in low protein expression and/or severe kinetic changes were those associated with the most severe phenotypes.

Original languageEnglish (US)
Pages (from-to)881-893
Number of pages13
JournalHuman Mutation
Volume36
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Congenital Myasthenic Syndromes
Choline O-Acetyltransferase
Genetic Association Studies
Mutation
Enzymes
Phenotype
HEK293 Cells
Apnea
Cholinergic Agents
Acetylcholine
Catalytic Domain
Proteins
Hot Temperature
Binding Sites

Keywords

  • ChAT
  • Enzyme kinetics
  • Genotype-phenotype correlations
  • Phosphorylation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome : Molecular Findings and Genotype-Phenotype Correlations. / Arredondo, Juan; Lara, Marian; Gospe, Sídney M.; Mazia, Claudio G.; Vaccarezza, Maria; Garcia-Erro, Marcela; Bowe, Constance M.; Chang, Celia H; Mezei, Michelle M.; Maselli, Ricardo A.

In: Human Mutation, Vol. 36, No. 9, 01.09.2015, p. 881-893.

Research output: Contribution to journalArticle

Arredondo, J, Lara, M, Gospe, SM, Mazia, CG, Vaccarezza, M, Garcia-Erro, M, Bowe, CM, Chang, CH, Mezei, MM & Maselli, RA 2015, 'Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations', Human Mutation, vol. 36, no. 9, pp. 881-893. https://doi.org/10.1002/humu.22823
Arredondo, Juan ; Lara, Marian ; Gospe, Sídney M. ; Mazia, Claudio G. ; Vaccarezza, Maria ; Garcia-Erro, Marcela ; Bowe, Constance M. ; Chang, Celia H ; Mezei, Michelle M. ; Maselli, Ricardo A. / Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome : Molecular Findings and Genotype-Phenotype Correlations. In: Human Mutation. 2015 ; Vol. 36, No. 9. pp. 881-893.
@article{c1b0d1e34a114af4a0dc8b845d5068b2,
title = "Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations",
abstract = "Choline acetyltransferase catalyzes the synthesis of acetylcholine at cholinergic nerves. Mutations in human CHAT cause a congenital myasthenic syndrome due to impaired synthesis of ACh; this severe variant of the disease is frequently associated with unexpected episodes of potentially fatal apnea. The severity of this condition varies remarkably, and the molecular factors determining this variability are poorly understood. Furthermore, genotype-phenotype correlations have been difficult to establish in patients with biallelic mutations. We analyzed the protein expression of phosphorylated ChAT of seven CHAT mutations, p.Val136Met, p.Arg207His, p.Arg186Trp, p.Val194Leu, p.Pro211Ala, p.Arg566Cys, and p.Ser694Cys, in HEK-293 cells to phosphorylated ChAT, determined their enzyme kinetics and thermal stability, and examined their structural changes. Three mutations, p.Arg207His, p.Arg186Trp, and p.Arg566Cys, are novel, and p.Val136Met and p.Arg207His are homozygous in three families and associated with severe disease. The characterization of mutants showed a decrease in the overall catalytic efficiency of ChAT; in particular, those located near the active-site tunnel produced the most seriously disruptive phenotypic effects. On the other hand, p.Val136Met, which is located far from both active and substrate-binding sites, produced the most drastic reduction of ChAT expression. Overall, CHAT mutations producing low enzyme expression and severe kinetic effects are associated with the most severe phenotypes. We investigated the expression and enzyme kinetics of seven phosphorylated choline acetyltransferase (ChAT) mutants causing congenital myasthenic syndrome. The enzyme kinetics of ChAT mutants expressed in HEK cells was investigated using the Fonnum method and the structure was analyzed using the Swiss-PdbViewer program. We found that ChAT mutants resulting in low protein expression and/or severe kinetic changes were those associated with the most severe phenotypes.",
keywords = "ChAT, Enzyme kinetics, Genotype-phenotype correlations, Phosphorylation",
author = "Juan Arredondo and Marian Lara and Gospe, {S{\'i}dney M.} and Mazia, {Claudio G.} and Maria Vaccarezza and Marcela Garcia-Erro and Bowe, {Constance M.} and Chang, {Celia H} and Mezei, {Michelle M.} and Maselli, {Ricardo A}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/humu.22823",
language = "English (US)",
volume = "36",
pages = "881--893",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome

T2 - Molecular Findings and Genotype-Phenotype Correlations

AU - Arredondo, Juan

AU - Lara, Marian

AU - Gospe, Sídney M.

AU - Mazia, Claudio G.

AU - Vaccarezza, Maria

AU - Garcia-Erro, Marcela

AU - Bowe, Constance M.

AU - Chang, Celia H

AU - Mezei, Michelle M.

AU - Maselli, Ricardo A

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Choline acetyltransferase catalyzes the synthesis of acetylcholine at cholinergic nerves. Mutations in human CHAT cause a congenital myasthenic syndrome due to impaired synthesis of ACh; this severe variant of the disease is frequently associated with unexpected episodes of potentially fatal apnea. The severity of this condition varies remarkably, and the molecular factors determining this variability are poorly understood. Furthermore, genotype-phenotype correlations have been difficult to establish in patients with biallelic mutations. We analyzed the protein expression of phosphorylated ChAT of seven CHAT mutations, p.Val136Met, p.Arg207His, p.Arg186Trp, p.Val194Leu, p.Pro211Ala, p.Arg566Cys, and p.Ser694Cys, in HEK-293 cells to phosphorylated ChAT, determined their enzyme kinetics and thermal stability, and examined their structural changes. Three mutations, p.Arg207His, p.Arg186Trp, and p.Arg566Cys, are novel, and p.Val136Met and p.Arg207His are homozygous in three families and associated with severe disease. The characterization of mutants showed a decrease in the overall catalytic efficiency of ChAT; in particular, those located near the active-site tunnel produced the most seriously disruptive phenotypic effects. On the other hand, p.Val136Met, which is located far from both active and substrate-binding sites, produced the most drastic reduction of ChAT expression. Overall, CHAT mutations producing low enzyme expression and severe kinetic effects are associated with the most severe phenotypes. We investigated the expression and enzyme kinetics of seven phosphorylated choline acetyltransferase (ChAT) mutants causing congenital myasthenic syndrome. The enzyme kinetics of ChAT mutants expressed in HEK cells was investigated using the Fonnum method and the structure was analyzed using the Swiss-PdbViewer program. We found that ChAT mutants resulting in low protein expression and/or severe kinetic changes were those associated with the most severe phenotypes.

AB - Choline acetyltransferase catalyzes the synthesis of acetylcholine at cholinergic nerves. Mutations in human CHAT cause a congenital myasthenic syndrome due to impaired synthesis of ACh; this severe variant of the disease is frequently associated with unexpected episodes of potentially fatal apnea. The severity of this condition varies remarkably, and the molecular factors determining this variability are poorly understood. Furthermore, genotype-phenotype correlations have been difficult to establish in patients with biallelic mutations. We analyzed the protein expression of phosphorylated ChAT of seven CHAT mutations, p.Val136Met, p.Arg207His, p.Arg186Trp, p.Val194Leu, p.Pro211Ala, p.Arg566Cys, and p.Ser694Cys, in HEK-293 cells to phosphorylated ChAT, determined their enzyme kinetics and thermal stability, and examined their structural changes. Three mutations, p.Arg207His, p.Arg186Trp, and p.Arg566Cys, are novel, and p.Val136Met and p.Arg207His are homozygous in three families and associated with severe disease. The characterization of mutants showed a decrease in the overall catalytic efficiency of ChAT; in particular, those located near the active-site tunnel produced the most seriously disruptive phenotypic effects. On the other hand, p.Val136Met, which is located far from both active and substrate-binding sites, produced the most drastic reduction of ChAT expression. Overall, CHAT mutations producing low enzyme expression and severe kinetic effects are associated with the most severe phenotypes. We investigated the expression and enzyme kinetics of seven phosphorylated choline acetyltransferase (ChAT) mutants causing congenital myasthenic syndrome. The enzyme kinetics of ChAT mutants expressed in HEK cells was investigated using the Fonnum method and the structure was analyzed using the Swiss-PdbViewer program. We found that ChAT mutants resulting in low protein expression and/or severe kinetic changes were those associated with the most severe phenotypes.

KW - ChAT

KW - Enzyme kinetics

KW - Genotype-phenotype correlations

KW - Phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=84938966597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938966597&partnerID=8YFLogxK

U2 - 10.1002/humu.22823

DO - 10.1002/humu.22823

M3 - Article

VL - 36

SP - 881

EP - 893

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 9

ER -